Anastrozole
Loading...Anastrozole Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
• kidney disease • a magnesium-restricted diet • stomach pain, nausea, or vomiting • a sudden change in bowel habits that lasts over 14 days taking a prescription drug. This product may interact with certain prescription drugs. • you have rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition. • you need to use a laxative for more than 1 week ask a health professional before use.
Ask a doctor before use if you haveAsk a doctor or pharmacist before use if you are
Stop use and ask a doctor if
If pregnant or breast-feeding,
In case of overdose, get medical help or contact a Poison Control Center right away. Keep out of reach of children.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- relieves occasional constipation (irregularity)
- generally produces bowel movement in 1/2 to 6 hours
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Anastrozole Manufacturers
-
Northwind Pharmaceuticals, Llc
![Anastrozole Tablet [Northwind Pharmaceuticals, Llc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Anastrozole | Tya Pharmaceuticals
• shake well before use • do not exceed the maximum recommended daily dose in a 24 hour period • dose may be taken once a day preferably at bedtime, in divided doses, or as directed by a doctor • drink a full glass (8 oz) of liquid with each dose adults and children 12 years and older: 2 to 4 tablespoonfuls children 6 to 11 years: 1 to 2 tablespoonfuls children under 6 years: ask a doctor
-
Cypress Pharmaceutical, Inc.
Anastrozole | Cypress Pharmaceutical, Inc.
2.1 Recommended Dose
The dose of Anastrozole is one 1 mg tablet taken once a day. For patients with advanced breast cancer, Anastrozole should be continued until tumor progression. Anastrozole can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial Anastrozole was administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Breckenridge Pharmaceutical, Inc.
Anastrozole | Breckenridge Pharmaceutical, Inc.
2.1 Recommended Dose
The dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)] 2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Kaiser Foundation Hospitals
Anastrozole | Kaiser Foundation Hospitals
2.1 Recommended Dose
The dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)] 2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Udl Laboratories, Inc.
Anastrozole | Udl Laboratories, Inc.
2.1 Recommended DoseThe dose of anastrozole tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for 5 years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild to moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Pack Pharmaceuticals, Llc
Anastrozole | Pack Pharmaceuticals, Llc
2.1 Recommended DoseThe dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [See Use in Specific Populations (8.7)]
-
Major Pharmaceuticals
Anastrozole | Major Pharmaceuticals
2. DOSAGE AND ADMINISTRATION
2.1. Recommended Dose
The dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]2.2. Patients with Hepatic Impairment
No changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)] -
Rebel Distributors Corp
Anastrozole | Rebel Distributors Corp
2.1. Recommended DoseThe dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
2.2. Patients with Hepatic Impairment
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]No changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Synthon Pharmaceuticals, Inc.
Anastrozole | Synthon Pharmaceuticals, Inc.
2.1 Recommended DoseThe dose of Anastrozole Tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, Anastrozole Tablets should be continued until tumor progression. Anastrozole Tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial Anastrozole Tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole Tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Kremers Urban Pharmaceuticals Inc.
Anastrozole | Kremers Urban Pharmaceuticals Inc.
2.1 Recommended DoseThe dose of Anastrozole Tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, Anastrozole Tablets should be continued until tumor progression. Anastrozole Tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial Anastrozole Tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole Tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Ascend Laboratories, Llc
Anastrozole | Ascend Laboratories, Llc
2. DOSAGE AND ADMINISTRATION
2.1. Recommended Dose
The dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]2.2. Patients with Hepatic Impairment
No changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)] -
Ascend Laboratories, Llc
Anastrozole | Ascend Laboratories, Llc
2. DOSAGE AND ADMINISTRATION
2.1. Recommended Dose
The dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]2.2. Patients with Hepatic Impairment
No changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)] -
Sun Pharmaceutical Industries Limited
Anastrozole | Sun Pharmaceutical Industries Limited
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole tablet was administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Boscogen, Inc.
Anastrozole | Boscogen, Inc.
2.1 Recommended Dose
2.2 Patients with Hepatic Impairment
The dose of Anastrozole is one 1 mg tablet taken once a day. For patients with advanced breast cancer, Anastrozole should be continued until tumor progression. Anastrozole can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial Anastrozole was administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]No changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
App Pharmaceuticals, Llc
Anastrozole | App Pharmaceuticals, Llc
2.1 Recommended Dose
The dose of anastrozole is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets 1 mg should be continued until tumor progression. Anastrozole tablets 1 mg can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole tablets 1 mg were administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)]. 2.2 Patients with Hepatic Impairment
No changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)]. -
Cadila Healthcare Limited
Anastrozole | Cadila Healthcare Limited
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablet should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years [see CLINICAL STUDIES (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see USE IN SPECIFIC POPULATIONS (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see USE IN SPECIFIC POPULATIONS (8.7)].
-
Dr. Reddy’s Laboratories Limited
Anastrozole | Dr. Reddy's Laboratories Limited
2.1 Recommended DoseThe dose of anastrozole is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole should be continued until tumor progression. Anastrozole can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole was administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [seeUse in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Rebel Distributors Corp
Anastrozole | Rebel Distributors Corp
2.1 Recommended DoseThe dose of anastrozole tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole was administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Roxane Laboratories, Inc.
Anastrozole | Roxane Laboratories, Inc.
2.1 Recommended DoseThe dose of anastrozole is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole should be continued until tumor progression. Anastrozole can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Pd-rx Pharmaceuticals, Inc.
Anastrozole | Genesis Pharmaceutical, Inc.
Apply liberally 15 minutes before sun exposure Reapply: after 40 minutes of swimming or sweating immediately after towel drying at least every 2 hours Children under 6 months: Ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses -
Golden State Medical Supply, Inc.
Anastrozole | Golden State Medical Supply, Inc.
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole tablet was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Dispensing Solutions, Inc.
Anastrozole | Dispensing Solutions, Inc.
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Major Pharmaceuticals
Anastrozole | Major Pharmaceuticals
2.1 Recommended DoseThe dose of anastrozole tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole was administered for five years. [see Clinical Studies (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see Use in Specific Populations (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see Use in Specific Populations (8.7)]
-
Kadmon Pharmaceuticals, Llc
Anastrozole | Kadmon Pharmaceuticals, Llc
2.1 Recommended DoseThe dose of anastrozole tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
American Health Packaging
Anastrozole | American Health Packaging
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablet should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years [see CLINICAL STUDIES (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see USE IN SPECIFIC POPULATIONS (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see USE IN SPECIFIC POPULATIONS (8.7)].
-
Zydus Pharmaceuticals (Usa) Inc.
Anastrozole | Zydus Pharmaceuticals (usa) Inc.
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablet should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years [see CLINICAL STUDIES (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see USE IN SPECIFIC POPULATIONS (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see USE IN SPECIFIC POPULATIONS (8.7)].
-
Bluepoint Laboratories
Anastrozole | Bluepoint Laboratories
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablet should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years [see CLINICAL STUDIES (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see USE IN SPECIFIC POPULATIONS (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see USE IN SPECIFIC POPULATIONS (8.7)].
-
Proficient Rx Lp
Anastrozole | Proficient Rx Lp
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Mylan Pharmaceuticals Inc.
Anastrozole | Mylan Pharmaceuticals Inc.
2.1 Recommended DoseThe dose of anastrozole tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole tablets were administered for 5 years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild to moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Apotex Corp.
Anastrozole | Apotex Corp.
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole tablet was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Teva Pharmaceuticals Usa Inc
Anastrozole | Teva Pharmaceuticals Usa Inc
2.1 Recommended DoseThe dose of anastrozole tablets is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole tablets were administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients With Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablets have not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Bryant Ranch Prepack
Anastrozole | Bryant Ranch Prepack
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole was administered for five years [see Clinical Studies (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
-
Sandoz Inc
Anastrozole | Sandoz Inc
2.1 Recommended DoseThe dose of anastrozole is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole should be continued until tumor progression. Anastrozole can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole was administered for five years. [see CLINICAL STUDIES (14.1)]
No dosage adjustment is necessary for patients with renal impairment or for elderly patients. [see USE IN SPECIFIC POPULATIONS (8.6)]
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment. [see USE IN SPECIFIC POPULATIONS (8.7)]
-
Accord Healthcare Inc.
Anastrozole | Accord Healthcare Inc.
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial, anastrozole was administered for five years [see Clinical Studies ( 14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see Use in Specific Populations ( 8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole has not been studied in patients with severe hepatic impairment [see Use in Specific Populations ( 8.7)].
-
American Health Packaging
Anastrozole | American Health Packaging
2.1 Recommended DoseThe dose of anastrozole tablet is one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablet should be continued until tumor progression. Anastrozole tablets can be taken with or without food.
For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets were administered for five years [see CLINICAL STUDIES (14.1)].
No dosage adjustment is necessary for patients with renal impairment or for elderly patients [see USE IN SPECIFIC POPULATIONS (8.6)].
2.2 Patients with Hepatic ImpairmentNo changes in dose are recommended for patients with mild-to-moderate hepatic impairment. Anastrozole tablet has not been studied in patients with severe hepatic impairment [see USE IN SPECIFIC POPULATIONS (8.7)].
![Anastrozole Tablet, Coated [Cypress Pharmaceutical, Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0193ddae-c600-4e80-a578-4fe271231991&name=label.jpg)
![Anastrozole Tablet [Breckenridge Pharmaceutical, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ca9d4aff-ffdf-4a46-ad20-e47e5886a19e&name=anas.fig1.jpg)
![Anastrozole Tablet [Kaiser Foundation Hospitals]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8d8cdd21-2403-4284-bdfc-d56d6e8ab117&name=anastrozole-06.jpg)
![Anastrozole Tablet, Film Coated [Udl Laboratories, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f881ec1a-d330-41d8-b633-143875c06ea4&name=f881ec1a-d330-41d8-b633-143875c06ea4-06.jpg)
![Anastrozole Tablet [Pack Pharmaceuticals, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4bd7e768-2d09-44e6-bacb-7390a5bc5dbc&name=anastro.fig5.jpg)
![Anastrozole Tablet [Major Pharmaceuticals]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4f6df9c0-b3a1-4ba0-83b9-ba06c69c2e08&name=anastrozole-tablets-6.jpg)
![Anastrozole Tablet [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=611e1f43-1442-4cbb-b7eb-b65de15c6c70&name=611e1f43-1442-4cbb-b7eb-b65de15c6c70-06.jpg)
![Anastrozole Tablet, Film Coated [Synthon Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b33520de-f891-43f8-bd04-1b66795d3dd2&name=anastrazole-06.jpg)
![Anastrozole Tablet, Film Coated [Kremers Urban Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d4550afa-977e-426e-814b-705435d2af81&name=13fc4e17-f66a-4835-86d7-74ac6492f443-06.jpg)
![Anastrozole Tablet [Ascend Laboratories, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4a23dc55-9877-4b43-ac2c-cd628c0f5038&name=AscendAnastrozoleTablets-1mgproductlabel.jpg)
![Anastrozole Tablet [Ascend Laboratories, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c7666def-a855-4ca3-a322-603a88a44101&name=ProductLabel.jpg)
![Anastrozole Tablet, Film Coated [Sun Pharmaceutical Industries Limited ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc6adb1b-00a2-40d7-ba92-799393fc689d&name=anastrozole-label.jpg)
![Anastrozole Tablet, Coated [Boscogen, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=188c6fd5-6695-4d8b-af43-61d9c26abfe9&name=label.jpg)
![Anastrozole Tablet [App Pharmaceuticals, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a96e22b2-eca3-4438-b959-dc5381085d31&name=anastrozole-label.jpg)
![Anastrozole Tablet, Coated [Cadila Healthcare Limited]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=965c4cb1-f6b8-47ac-bf13-c36639aa908f&name=anastrozoletablet(manu)-figure-08.jpg)
![Anastrozole Tablet, Film Coated [Dr. Reddy’s Laboratories Limited]](http://recallguide.cwdevelopsp.com/wp-content/themes/recallguide/assets/img/drug-image-placeholder.jpg)
![Anastrozole Tablet [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d4f43676-0746-4765-9689-3f1e3075fa6a&name=d4f43676-0746-4765-9689-3f1e3075fa6a-06.jpg)
![Anastrozole Tablet [Roxane Laboratories, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5d7d3cfa-af46-48fd-afee-cddf39d2efde&name=bottle.jpg)
![Anastrozole Tablet [Pd-rx Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6272644b-c96a-4480-b34d-937621ecc563&name=glytone-sunscreen-lotion-spf-40-1.jpg)
![Anastrozole Tablet, Film Coated [Golden State Medical Supply, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=35c8037f-2601-4bd3-b423-2f53af7c0be3&name=86bc1658-398a-4e87-8c6f-a4202255de82-08.jpg)
![Anastrozole Tablet [Dispensing Solutions, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ddc99d79-fb94-4a91-9c39-9dcdb3dd5d5b&name=NDC66336-0533-XX------ACCORD.jpg)
![Anastrozole Tablet [Major Pharmaceuticals]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e46ed5b8-83c9-4adb-890f-0fc612371eea&name=anastrozole-tablet-6.jpg)
![Anastrozole Tablet, Film Coated [Kadmon Pharmaceuticals, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8e4f7179-81d7-4715-9cc1-babef97fcca0&name=37ab9c22-1f7c-4a54-a143-753b353d96a4-06.jpg)
![Anastrozole Tablet, Coated [American Health Packaging]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc0a61a2-78b2-46f7-9933-63fed2c1cebc&name=image-05.jpg)
![Anastrozole Tablet, Coated [Zydus Pharmaceuticals (Usa) Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ca16f8de-d9a5-4c6c-957b-ae28497b67ac&name=anastrozoletabs-figure-08.jpg)
![Anastrozole Tablet, Coated [Bluepoint Laboratories]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3cd04ed6-7c5a-4c4a-9955-ee40839dfea0&name=AnastrozoleTablets1mg30tabletsRev0913.jpg)
![Anastrozole Tablet [Proficient Rx Lp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c7a36fd8-530e-4c63-97d5-0f80fab5880e&name=anastrozole-1mg-30-label.jpg)
![Anastrozole Tablet, Film Coated [Mylan Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5ad69fab-7469-419e-9c52-662e07e52c86&name=ad8c7875-efe0-44f6-8c99-0ed81135fe95-08.jpg)
![Anastrozole Tablet, Film Coated [Teva Pharmaceuticals Usa Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c58c7013-50a0-4734-8a78-38ff20a3e7eb&name=327d6dd3-df90-41ca-bf77-8426c40c791a-08.jpg)
![Anastrozole Tablet [Bryant Ranch Prepack]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=19251d0b-279a-49f5-99b2-0e74d7cca479&name=52691.jpg)
![Anastrozole Tablet, Film Coated [Sandoz Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6128eda4-ad33-4c23-8d93-5192421fd8d0&name=b97c8f13-43ad-4130-b6ec-e945cb77d55d-08.jpg)
![Anastrozole Tablet [Accord Healthcare Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=03586c40-eb32-45c5-beb7-6762a6b78790&name=anastrozole-1mg-30-label.jpg)
![Anastrozole Tablet, Coated [American Health Packaging]](https://www.recallguide.org/wp-content/themes/bootstrap/assets/img/drug-image-placeholder.jpg)
Login To Your Free Account